Corbus Pharmaceuticals Holdings, Inc. (CRBP) Stock: A Strong Pick In The Biotech Space?


Corbus Pharmaceuticals Holdings, Inc. (CRBP) is falling in the market today. The company, focused on the biotech space, is presently priced at $4.51 after falling -7.96% so far today. In terms of biotech stocks, there are quite a few aspects that have the ability to cause declines in the market. One of the most common is news. Here are the recent trending headlines surrounding CRBP:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-07-19 11:15AM Corbus Pharmaceuticals (CRBP) Reports Q3 Loss, Tops Revenue Estimates
07:05AM Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
Nov-05-19 01:00PM 3 Under-the-Radar Stocks Top Insiders Are Snapping Up
Nov-04-19 08:05AM Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019
Nov-01-19 12:08PM Were Hedge Funds Right About Selling Corbus Pharmaceuticals (CRBP)?

Nonetheless, when making a decision with regard to investing, investors should take a look at much more than news, this is especially the case in the speculative biotech sector. Here’s what’s happening with Corbus Pharmaceuticals Holdings, Inc..

Recent Movement From CRBP

Although a single session decline, like the move that we’re seeing from Corbus Pharmaceuticals Holdings, Inc. might cause fear in some investors, a single session move by itself should not be the basis of a decision to, or not to, invest in a stock. It is always important to look at trends experienced by the stock just a single trading day. As it relates to CRBP, below are the returns that investors have experienced:

  • Weekly – Throughout the last 5 trading sessions, CRBP has generated a change in price that amounts to -12.77%.
  • Past 30 Days – The ROI from Corbus Pharmaceuticals Holdings, Inc. throughout the last month has been -2.38%.
  • Past Quarter – Over the last quarter, the company has produced a ROI that comes to -23.30%
  • Past 6 Months – Throughout the last 6 months, investors have seen a change of -39.95% from the company.
  • YTD – Since the open of this year CRBP has produced a return of -22.77%.
  • Annually – Finally, in the past year, we’ve seen movement in the amount of -38.22% out of CRBP. Throughout this period, the stock has traded at a high of -50.49% and a low price of 3.11%.

Rations That Investors Should Think About

Looking at a few key ratios having to do with a stock generally gives investors a view of how risky and/or potentially profitable a an investment option may be. Below are some of the key ratios to consider when looking at CRBP.

Short Ratio – The short ratio is a tool that’s used to measure the amount of short interest. As the short ratio goes higher, it shows that more investors have a belief that the value of the stock is going to go down. In general, biotechnology stocks can come with a higher short ratio. On the other hand, we also tend to see quite a few short squeezes in the sector. Nonetheless, in relation to Corbus Pharmaceuticals Holdings, Inc., it’s short ratio amounts to 27.93.

Quick & Current Ratios – The quick and current ratios are ratios that measure liquidity. Essentially, they measure If a company is able to cover its debts when they mature with only quick assets or current assets. Because many biotech many companies rely heavily on the continuation of investor support, the current and quick ratios can seem bad. However, some better companies in the biotechnology sector come with great quick and current ratios. As far as CRBP, the quick and current ratios work out to 2.60 and 2.60 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the book value of assets owned by the company. In this case, that ratio comes in at 0.73.

Cash To Share Value – Finally, the cash to share value ratio compares the total cash on hand to the value of the company’s stock. Several early stage biotech companies struggle to keep cash on hand. So, when investing in the biotechnology space, this is a very important ratio to consider. In this case, the cash to share value ratio works out to 1.14.

What Analysts Think About Corbus Pharmaceuticals Holdings, Inc.

Although it’s not a good idea to blindly follow the thoughts of analysts, it is a good idea to consider their opinions in order to validate your own opinions before making an investment decision in the biotech space. Below you’ll find the most recent moves that we’ve seen from analysts with regard to CRBP.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-05-19 Initiated Jefferies Buy
Mar-20-19 Initiated Oppenheimer Outperform $28
Jan-11-19 Reiterated Cantor Fitzgerald Overweight $36 → $38
Dec-26-18 Initiated H.C. Wainwright Buy $24
Dec-07-18 Initiated RBC Capital Mkts Outperform $23

Is Big Money Interested in Corbus Pharmaceuticals Holdings, Inc.?

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in CRBP, here’s what we’re seeing:

Institutions own 51.50% of the company. Institutional interest has moved by 0.12% over the past three months. When it comes to insiders, those who are close to the company currently own 1.00% percent of CRBP shares. Institutions have seen ownership changes of an accumulative 3.95% over the last three months.

Looking At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 64.02M shares of Corbus Pharmaceuticals Holdings, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, CRBP has a float of 61.11M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to CRBP, the short percent of the float is 26.79%.

Financial Results And Expectations

What have ween seen from CRBP in terms of financial results?Here’s the data:

  • Analyst Expectations – Currently, analysts are expecting that Corbus Pharmaceuticals Holdings, Inc. will report earnings per diluted share of -1.79, with -0.38 to be announced in the report for the current quarter. Although this data is not tide to earnings, because we’re chatting about Wall Street analysts, Corbus Pharmaceuticals Holdings, Inc. is presently rated a 1.60 considering a scale that ranges from 1 to 5 where 1 is the worst average analyst grade and 5 is the best rating.
  • 5-Year Sales – Throughout the last 5 years, Corbus Pharmaceuticals Holdings, Inc. has created a movement in revenue that comes to a total of 0. Earnings in the past half decade have experienced movement in the amount of 0.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is generally explained in today’s society, the company has generated a change in earnings in the amount of 114.90%. The company has also seen a change in regard to revenue in the amount of 3308.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was created by a human and human beings play a crucial role in my ability to learn. Sure, I can look through social media trends and other publicly available information, but, like humans, I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I’d love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, leave a comment below and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here